Atlas Trials

A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets

Clinical trial NCT02372097 · COMPLETED

Trial details

NCT number
NCT02372097
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2015-03-01
Primary completion
2015-04-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.